接受较低强度治疗的成人 AML 的遗传风险分类：2024 年 ELN 建议。
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations.
发表日期：2024 Aug 12
作者：
Hartmut Döhner, Courtney D DiNardo, Andrew H Wei, Bob Löwenberg, Frederick Appelbaum, Charles Craddock, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert J Ossenkoppele, Christoph Röllig, Jorge Sierra, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jianxiang Wang, Agnieszka Wierzbowska
来源：
BLOOD
摘要：
欧洲白血病网 (ELN) 遗传风险分类是根据接受强化化疗的年轻人的数据制定的。对接受强度较低治疗的患者进行的最新分析提出了专门针对该患者群体的 ELN 遗传风险分类的建议。版权所有 © 2024 美国血液学会。
The European LeukemiaNet (ELN) genetic risk classifications were developed based on data from younger adults receiving intensive chemotherapy. Emerging analyses from patients receiving less-intensive therapies prompted a proposal for an ELN genetic risk classification specifically for this patient population.Copyright © 2024 American Society of Hematology.